Podcast: Play in new window | Download
Summary
On episode 449 of 40+ Fitness, Coach Allan sits down with Dr. Nir Barzilai, founding director of the Institute for Aging Research at Albert Einstein College of Medicine, science director of the American Federation for Aging Research, and the researcher who discovered the first longevity gene in humans.
Nir explains why his team studies “super-agers,” people who are still healthy at 95, to uncover the biological traits that let some people outlive their peers by decades.
The conversation covers what actually predicts a longer healthspan (cholesterol patterns, growth hormone signaling, mitochondrial communication), why replacing declining hormones with testosterone, estrogen, or growth hormone can backfire, and why metformin and properly timed fasting show more promise than most trendy anti-aging fixes.
Links
- https://www.afar.org
Key Takeaways
- “Super-agers” are defined by health, not just years lived. Barzilai's centenarian study only counted people who were still healthy and independent at 95, because the goal was finding the genetics behind exceptional healthspan, not just a long lifespan.
- High HDL cholesterol that does not decline with age is a longevity marker. In most people HDL drops steadily as they age, but centenarians keep theirs high throughout life, and the genetic variants behind that trait have already led to two drugs in development.
- Blunted growth hormone and IGF-1 signaling shows up in most centenarians. More than 60 percent of Barzilai's super-agers have mutations that reduce this pathway, supporting the idea that at some point the body has to shift energy from growth toward defense and repair.
- Replacing hormones to fight aging can do more harm than good. Growth hormone, testosterone, and estrogen all decline with age, but restoring them has not held up as a longevity strategy: growth hormone mainly melts fat under the skin rather than building real strength, and both testosterone and estrogen carry more risk than benefit in older adults.
- Mitochondria send their own hormone-like messages throughout the body. Barzilai's research identified mitochondrial-derived peptides, signals made by the mitochondria that influence tissues elsewhere in the body, which is the basis of the therapies his company is developing.
- Aging researchers now think in terms of interconnected “hallmarks,” not one root cause. Targeting one hallmark, like reduced autophagy (the cell's garbage disposal system), tends to ripple out and improve others, including mitochondrial function, metabolism, and immunity.
- COVID-19 exposed how aging itself is the biggest risk factor for severe disease. An 80-year-old is roughly 200 times more likely to die of COVID than a 20-year-old, largely because of declining immune function and an unchecked inflammatory response, both of which are hallmarks of aging.
- Metformin is being tested to prove aging itself can be treated. The TAME trial (Targeting Aging with Metformin) uses this 80-year-old, generic, well-understood diabetes drug specifically because it is cheap and safe, and existing data already links it to less cancer, less cardiovascular disease, and lower mortality even in people who started out sicker than average.
- How you fast matters more than how much you cut calories. When Barzilai's lab gave calorie-restricted animals all their food in one sitting instead of spreading it through the day, the animals still got thinner but did not live longer, suggesting the daily fasting window itself, not just eating less, drives the benefit.
“We understand now that aging is flexible and we can target it.”
Dr. Nir Barzilai
Another Episode You May Enjoy
Episode 456 – How to thrive during menopause with Amanda Thebe
